Nippon India Mutual Fund launches Nippon India Nifty Pharma ETF

NFO period: 21^st June – 28^th June, 2021

Highlights of the NFO:

• Scheme type – An open ended scheme replicating/ tracking NIFTY Pharma Index


• Investment objective – The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the scheme will be achieved.


• Product suitability – The product is suitable for investors who are seeking Long term capital growth by investing in equity and equity related securities and portfolios replicating the composition of Nifty Pharma Index, subject to tracking errors.


• Minimum Application Amount – First investment is Rs. 1,000/- and in multiples of Rs. 1/- thereafter


• Plan/ Options available – Presently the scheme does not offer any Plans/Options for investment.


• Fund Managers – Mr. Mehul Dama


• Benchmark – NIFTY Pharma TRI